Author

Santa-Mariela Olivera-Ugarte

Observed names: S. Olivera, Santa Mariela Olivera Ugarte, Santa Olivera, Santa-M. Olivera-Ugarte

Institution: Centre de recherche du CHU de Québec-Université Laval

Observed institutions: Heidelberg University, Centro de Ingeniería Genética y Biotecnología, Université Laval, Centre de recherche du CHU de Québec-Université Laval

ORCID: 0000-0002-1229-8399

Observed ORCID: 0000-0002-1229-8399

OpenAlex ID: A5024426127

Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System

2016 · G. Martínez-Donato, B. Piniella, et al. · Clinical and Vaccine Immunology · 42

Protective cellular immune response against hepatitis C virus elicited by chimeric protein formulations in BALB/c mice

2020 · Santa Olivera, Angel Perez, et al. · Archives of Virology · 18

Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity

2021 · Marie-Eve Laliberté-Gagné, Marilène Bolduc, et al. · Vaccines · 17

A Nanoparticle-Based COVID-19 Vaccine Candidate Elicits Broad Neutralizing Antibodies and Protects Against SARS-CoV-2 Infection

2022 · Santa-Mariela Olivera-Ugarte, Marilène Bolduc, et al. · Nanomedicine Nanotechnology Biology and Medicine · 14

RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response

2025 · Teng-Feng Li, Paul Rothhaar, et al. · Frontiers in Immunology · 4

Author Reply to Peer Reviews of RBM39 shapes innate immunity through transcriptional and splicing control of key factors of the interferon response

2024 · Teng-Feng Li, Paul Rothhaar, et al. · 1

Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 Variants

2026 · Léa-J. Blanchette, Marilène Bolduc, et al. · Vaccines

Works count: 7

Citation count: 96

H-index: 4

I10-index: 4